A Study Of Bronchial Stent Microbiome

Overview

About this study

The purpose of this study is to characterize the development and composition of bronchial stent microbiome from baseline through 30-60 days post-placement using gene sequencing.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 or greater

  • Bronchial airway stent requiring washout/stent replacement

  • Appointment scheduled on OR 101

  • Ability to undergo informed consent

 

Exclusion Criteria: 

  • Active respiratory infection requiring treatment at enrollment

  • Immunosuppression, with the exception of lung transplant patients

  • Pregnancy or breastfeeding

  • Current enrollment in any interventional trials affecting the endobronchial microbiome

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 08/11/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amjad Kanj

Open for enrollment

Contact information:

Pulmonary Clinical Research Unit

(800) 753-1606

PCRUE18@mayo.edu

More information

Publications

Publications are currently not available